Stocktoria
Raphael Pharmaceutical Inc. RAPH
OTC · OOTC · stock
Raphael Pharmaceutical Inc. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Return on assets | -2413.2% | -5625.9% | -562.3% | -1008.4% | -384.8% | -222.3% |
| Return on equity | 89.3% | 204.7% | -1256.1% | -3167.9% | -1268.8% | 1669.8% |
| Current ratio | 0.03 | 0.03 | 1.80 | 1.46 | 1.44 | 0.88 |
Source: SEC EDGAR filings · CIK 0001415397 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.